Genecapture, Inc.
Huntsville, AL
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 601 Genome Way Northwest #3023, Huntsville, AL 35806, USA
- Website
- genecapture.com
- Founded
- 2009
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $490,339 |
| FY2024 | $3,252,504 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Genecapture, Inc. is a for-profit startup company registered to receive federal contract awards since July 27, 2011. The company specializes in developing rapid infectious disease detection solutions using their patented CAPTURE technology, which identifies genetic signatures of pathogens. Genecapture has received multiple Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program contracts from various defense agencies to advance infectious disease diagnostic capabilities. These contracts focus on developing fieldable diagnostic platforms for rapidly identifying and testing antibiotic susceptibility of pathogens, particularly for point-of-care applications in military and medical settings.
The company has been awarded several contracts by defense agencies, including the Defense Health Agency (DHA), Defense Threat Reduction Agency (DTRA), Department of the Army Medical Command, and Department of the Air Force. Notable projects include expanding rapid portable invasive fungal infection diagnostics for wound infections, developing infectious disease diagnostics to differentiate between viral and bacterial infections, and creating a fieldable diagnostic platform for rapid identification and antibiotic susceptibility testing of wound pathogens. Many of these contracts were awarded under small business set-aside designations, with values ranging from approximately $50,000 for Phase I SBIR contracts to over $4.5 million for a Phase III STTR contract. Genecapture's work primarily supports military medical needs, focusing on improving diagnostic capabilities for infectious diseases in various operational environments, from forward-deployed settings to point-of-care applications.
Quick answers
Is Genecapture, Inc. registered in SAM.gov?
Yes. Genecapture, Inc.'s SAM.gov registration is active through January 8, 2027.
What is Genecapture, Inc.'s CAGE code?
Genecapture, Inc.'s CAGE code is 6GNB3, and its Unique Entity ID (UEI) is LVKCTP3NJ1K1.
How much has Genecapture, Inc. received in federal contracts?
Federal contracts obligated $490,339 to Genecapture, Inc. in fiscal year 2025 and $3,742,843 in fiscal years 2023 through 2027.
What is Genecapture, Inc.'s most recent federal award?
Genecapture, Inc.'s most recent federal contract award is DHA phase I sbir for project titled, "expanding genecapture's rapid portable invasive fungal infection (IFI)… (HT942524P0044), from Defense Health Agency, on February 5, 2024.
On GovTribe
See Genecapture, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors